Table 1 Key clinical characteristics, histopathology, and molecular pathology of three DICER1-associated sarcomas

From: Expanding the spectrum of dicer1-associated sarcomas

Demographics

Clinical characteristics

Histopathology

Molecular pathology

Outcomes

Patients

Age at diagnosis

Gender

Site of sarcoma

Other DICER1-associated conditions

Family history

Gross features

Rhabdomyoblastic differentiationa

Anaplasia

Chondroid/myxoid differentiation

Bone/osteoid formation

Immunohistochemical stains

Initial diagnosisb

DICER1 mutation(s)

Other genetic alterations

Final diagnosis

Positive

Negative

 

Somatic

Germline

Patient 1

5

F

Ovary

None

Mother: benign thyroid nodules

Paternal grandmother: thyroid cancer

Paternal great uncle: Brain tumor (DOD)

Oophorectomy specimen: fragments of torsed and ruptured ovarian tissue, measuring

8 × 6 × 4.8 cm in aggregate

Present

Present

Present

Present

Desmin

myogenin

SALL4

AE1/AE3

inhibin A

calretinin

INI1 (retained)

GFAP

NKX2.2

SOX10

High-grade pleomorphic sarcoma

c.2223_2230del; p.S742T*16

c.5425G>A;p.G1809R

c.2223_2230del; p.S742T*16

None

DICER1-associated ovarian sarcoma

Alive; radiographic remission 13-months off therapy

Patient 2

16

F

Peritoneum

Papillary thyroid microcarcinoma

None

Oophorectomy and peritoneal mass specimens: unknown

Autopsy: multiple tumor nodules, measuring 3.5–4.8 cm in peritoneum and omentum. Extensive abdominal, sub-diaphragmatic, and mediastinal lymphadenopathy was also identified.

Present

Present

Present

Present

Peritoneal mass: desmin

Myogenin

MyoD1

p53: 20% of the SRBC

Autopsy: desmin

S100 (partial)

Peritoneal mass: calretinin

CD10

Cytokeratin 7

EMA

Inhibin A

WT1

Autopsy (post chemotherapy): myogenin

WT1

CK7

CD34

CD10

CD68

Outside hospital: mature cystic teratoma

Re-review at our institution: adenosarcoma with rhabdomyosarcomatous overgrowth

c.3682C>T;p.Q1228*

c.5428G>T;p.D1810Y

Not tested

NRAS:vc.181C>A; p.Q61K

DICER1-associated peritoneal sarcoma

DOD

Patient 3

4

M

Brain

None

Maternal aunt: unknown cancer

Hemicraniectomy specimen: tumor tissue fragments measuring 2.3 × 2.1 × 0.9 cm in aggregate

Present

Present

Present

Absent

Desmin

Myogenin

MyoD1 (focal)

TLE1

BCOR and CD99 (patchy, weak)

Ki67 > 95%

INI-1 (retained) BRG1 (retained)

SMA

AE1/AE3

GFAP

EMA Synaptophysin

Olig2

S100

Primitive embryonal tumor with embryonal rhabdomyosarcomatous elements

c.5439G>C;p.E1813D

Not tested

GLI2c

IGFR1c

TSC2c

LOH 11p15.5

Loss 14q32.12

Gain 8q11.21

DICER1-associated primary intracranial sarcoma

DOD

  1. F female, M male, DOD died of disease, SRBC small round blue cell, LOH loss of heterozygosity
  2. aIncluding small round blue cells and spindle cells supported by IHC
  3. bPrior to molecular testing, based solely on histopathologic review
  4. cVariants of unknown clinical significance